ezetimibe has been researched along with azelastine in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (azelastine) | Trials (azelastine) | Recent Studies (post-2010) (azelastine) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 564 | 160 | 112 |
| Protein | Taxonomy | ezetimibe (IC50) | azelastine (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 6.3096 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
1 review(s) available for ezetimibe and azelastine
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |